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ABSTRACT
Sequence Specific Concentration and Labeling of Bacterial Plasmids for Future use in Detection
of Drug-Resistant Sepsis Cases without Amplification
Robert L. Hanson
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
Rapidly diagnosing the precise drug resistance present in sepsis-inducing bacteria is a
continuing need to maintain the efficacy of our medical systems. Diagnostics currently being
developed for such scenarios are either sensitive or rapid, but not both. Sequence-specific single
DNA molecule analysis could fill this gap if it could be adapted to work on smaller targets,
similar to those produced by classical biological methods. In this work, I demonstrate that
immobilized ssDNA in the appropriate hybridization buffer can rapidly pull its complementary
sequence out of solution. I also demonstrate that such systems in a microfluidic chip can be used
to capture bacterial plasmids as a step toward subsequent multiplexed analysis. Finally, I
demonstrate that a 120 bp double stranded polynucleotide with an overhanging single stranded
25 bp probe sequence can be modified with multiple fluorophores and used to label captured
targets in a sequence-specific manner. This system shows that it is possible to label bacterial
plasmids in a manner that can bridge the technological gap between single molecule counting
and small oligonucleotide targets. Such a system can achieve lower limits of detection for
clinically relevant samples while maintaining rapid processing times.
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1. SEPSIS, DRUG RESISTANCE, AND THE NEED FOR RAPID DETECTION
SYSTEMS*
1.1. Introduction
Sepsis is a life-threatening condition that occurs when chemicals are released by the
immune system into the blood in response to an infection. Their purpose is to destroy the
bacterial infection by killing the bacteria directly or by creating a hostile environment for the
organism’s growth. While acute conditions from these chemicals and activated immune cells can
often end an infection and promote health, the prolonged systemic presence of this response can
quickly result in tissue damage and multiple organ failure. Thus, septic patients can experience
failure of the kidneys, lungs, or cardiovascular system1. Even if a patient survives this condition,
they often experience long-term health complications as a result of the event. Complications can
include a suppressed immune system and impaired cognitive functions2. With such high stakes
attached to sepsis, it is recommended that healthcare providers begin treatment as quickly as
possible3. It is estimated that sepsis is involved in one third of all hospital deaths in the United
States4, costing the U.S. hospital system up to 24 billion annually in 20135.
While many steps such as replacing fluids and ensuring adequate blood supply need to be
taken to mitigate the effects of sepsis; none of these actions matter if the instigating infection
isn’t dealt with at the same time3. In earlier times, this was accomplished by simply treating the
patient with broad spectrum antibiotics that were designed to kill most bacteria. Inadvertently,
this practice resulted in killing off all but the most resilient strains that became the progenitors of
the current generation of infectious bacteria. Unfortunately, broad-spectrum antibiotics are now
severely limited in their ability to combat drug-resistant bacteria that cause sepsis. This has
*Figure 1.2 is adapted with permission from Hanson, Robert L.; Lazalde, Elaine; Knob, Radim;
Harris, David H.; Akuoko, Yesman; Nielsen, Jacob; Woolley, Adam T. Multilabel hybridization
probes for sequence-specific detection of sepsis-related drug resistance genes plasmids. Talanta
Open. 2021, 3, 100034
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exacerbated what is already considered to be a critical condition6. If the current generation of
sepsis inducing bacteria are to be treated effectively, methods for obtaining rapid and accurate
diagnostic information regarding drug resistance will be needed.

1.2. Diagnosing and Treating Sepsis
Because administering an effective antibiotic quickly is critical for effectively treating
sepsis, determining the presence of drug resistant strains of bacteria has become a vital point of
concern for healthcare providers. Through events like lateral plasmid transfer, key drug
resistance genes such as KPC, NDM, VIM, and IMP, have been able to spread throughout
bacterial populations faster than anticipated given normal evolutionary pressures7–9. In 2013 the
CDC reported the existence of strains of Carbapenem-Resistant Enterobacteriaceae (CRE) that
are resistant to all or nearly all known antibiotics10. At the present, hospitals from all states in the
U.S. have reported cases involving these types of bacterial infections11. Such strains have further
complicated the treatment of sepsis, since antibiotics used to treat bacterial infections must now
be matched to the strain’s susceptibility.
Information on a bacteria’s drug resistance profile is also critical for improving our
hospital system’s overall antibiotic stewardship. Improvement of these practices reduces the
speed at which drug resistance evolves and spreads, and in some cases, improved antibiotic
stewardship has been shown to reverse some drug-resistance trends12. This provides additional
incentive for rapid diagnostic tests that can inform of the drug-resistance capabilities of the
strains infecting patients.
Such information can be determined empirically by culturing the infecting bacteria from
blood on a plate spotted with various antibiotics. While such information is usually decisive, it
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often requires 24-48 hours to culture the bacteria in a clinical laboratory13,14, well outside the
recommended timeframe to begin administering antibiotics.
An improved method is to detect the presence of genes that confer drug resistance by
analyzing a bacteria’s DNA for specific sequences via qPCR15,16. qPCR creates thousands of
identical copies of a chosen target sequence if it is present in the original sample. This method
only takes a few hours, but qPCR runs inherent risks of false negative results due to
amplification interferences introduced by red blood cells or other compounds found in blood.
Purification procedures can mitigate some of these risks but this adds to the time required to
obtain useful information.
Another method of obtaining such information involves the use of matrix assisted laser
desorption ionization time of flight mass spectrometry17,18. By embedding the target cells in a
matrix of organic material, a sample can be ionized by a laser without destroying the key
biological information needed to identify it. This allows the subsequently recorded biochemical
fingerprint produced by the mass spectrometer to be compared to a library of known drug
resistant bacterial strains. However, the equipment for this process is relatively expensive and
requires skilled operator input. Clearly, there is a need for a point-of-care test that can provide
relevant diagnostic information regarding a bacterial strain’s drug resistance profile in less than
an hour.
An ideal protocol for obtaining the drug resistance profile of a bacterial infection would
address the challenges posed by components in the blood that interfere with the isolation and
identification of specific DNA sequences. It would also avoid false positives that result from
mismatched sequences interacting with one another. Finally, if the developed protocol could
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detect the genes conferring drug resistance without the need for amplification it would represent
a dramatic improvement in the speed and quality of diagnostic capabilities.

1.3. Diagnostic information for sepsis drug resistance in less than an hour
To meet the need for faster diagnostic information, the FASTBAC collaboration was
formed in 2015 by the Hawkins, Schmidt, Woolley, Pitt, and Robison research groups. I sought
to work with these collaborators to create a single platform capable of identifying the presence of
bacteria and key drug resistance genes in less than an hour. Figure 1.1 schematically shows three
modules, each of which addressed the key challenges associated with antibiotic resistance
determination as described in section 1.2. Module 1 (green) sought to address the challenges
posed by the presence of blood components that interfere with analysis of DNA. Module 2 (blue)
focused on isolating key target DNA sequences that need to be identified from a mixture of
chemically similar molecules. Module 3 (pink) would solve the optics challenges that come
when a low number of targets need to be detected without amplification.
The first module, designed by Dr. Pitt’s research group, was designed to isolate bacterial
DNA from all the other elements found in a blood drawn sample that might interfere with
downstream analysis. Their final goal was to isolate DNA from as few as 100 bacteria from 7
mL of blood in a volume of 100 µL in preparation for single-molecule detection. Using a novel
rotary system capable of separating erythrocytes from plasma without destroying or losing
bacterial cells in ~ 2 min19, Pitt and coworkers subsequently lysed and captured the bacterial
DNA20. The system created by Pitt’s group is able to obtain partially fragmented bacterial DNA
from E. coli cells that had been spiked into a blood sample in ~40 min21.
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A key feature of the system proposed in module 3 centered around an anti-resonant
reflecting optical waveguide (ARROW) developed by the Hawkins and Schmidt groups. This
specific waveguide makes possible the fluorescence detection of individual biological molecules
tied to specific diseases22. The technology represents a technical advance towards detecting key
targets without amplification as long as they are large enough to hold the appropriate number of
fluorophores23. Another advantage of this system is its capacity to detect multiple targets
simultaneously24. Typically, the ARROW optics system used by Schmidt’s research group
worked best when the DNA from the 100 µL was concentrated down to a volume of 3 µL with
little to no extraneous molecules that would raise the background noise.

Figure 1.1 Schematic for proposed system to detect DNA sequences related to drug resistance in sepsis. The device
contains single molecule optics integrated with purification technologies. (Module 1) Bacterial filtration and DNA
extraction. (Module 2) DNA concentration and labeling. (Module 3) Single-molecule optical analysis.

My focus has been on the development of module 2. This system would need to be able
to concentrate ~2 kbp fragmented ssDNA targets from 100 µL down to 3 µL. It would also need
to fluorescently label them, performing both steps in a sequence-specific manner. The following
sections discuss principles and processes for module 2 to ensure that it would produce a labeled
target suitable for analysis by the optical system of module 3.
5

1.4. DNA Hybridization
Because of its highly conserved structure, DNA can easily be synthesized and designed to
capture a complementary sequence. This is unique among methods of purification as it can
capture specific targets out of a mixed sample of chemically similar molecules25,26. From the
initial work of attaching DNA to membranes27, this concept has been applied in a variety of
systems as the years have progressed. Currently under investigation, it has been hypothesized
that capture of a complementary sequence could silence genes that cause disease when they are
overexpressed28; Lim utilized the technology in pulldown procedures29, and Egawa et al.
demonstrated its potential use for in vivo tagging procedures30.
Hybridization using peptide nucleic acids has shown that with slight modifications, the
strength of binding can be tuned31. When DNA hybridization involved targets of 100 bp or
less15,32, appropriate signal has been achieved by generating enough copies of the target so that
the fluorescence induced is above the limits of detection. Such features are suitable for research
targeted towards elucidating cell signaling pathways and basic biological questions but impose a
limitation on the ability to rapidly detect sepsis-related drug resistance at concentrations seen in a
clinical setting.
A target DNA sequence can be captured by a complementary sequence immobilized on a
solid surface, to isolate and preconcentrate target molecules without making new copies33,34.
These targets can then be hybridized with a secondary DNA sequence modified with a
fluorophore to label the captured target sequence35. Since both interactions are specific to their
complementary sequence, the resulting labeled complex would provide clear yes/no data for the
presence of the target DNA sequences. The specificity of such an interaction can also be
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increased by tailoring the specific number of base pairs to be hybridized and by conducting the
hybridization at a temperature warm enough that mismatched sequences will fail to hybridize
while the perfectly matched sequence’s ability to hybridize remains unaffected36. Finally, by
making the labeling sequence longer or more stable than the capture sequence, the label will not
dissociate from the target when the captured sequence is removed from the concentrating
surface37.
To ensure that the sequences we worked with would be relevant to antibiotic resistance genes
and bacteria identification in sepsis cases, Prof. Rich Robison’s lab identified the sequences
shown in Table 1.1. These sequences were analyzed via the BLAST search tool to ensure that
they were unique to their target gene or species with a 1% or less probability of being present in
other plasmids or species. All of these sequences have been seen in clinical isolates of patients
dealing with sepsis and drug resistance.
Table 1.1 Sequences commonly seen in cases of sepsis-related drug resistant bacteria. (Target) The sepsis-related
drug-resistance gene or bacterial strain targeted for detection. (Capture sequence) The complementary DNA sequence
that will be immobilized to the solid phase.

Target organism/plasmid
KPC
VIM
NDM
IMP
Escherichia coli
Enterobacter aerogenes
Enterobacter cloacae
Klebsiella pneumoniae

Capture sequence
TATCGCCGTCTAGTTCTGCTGTCTTG
TCGGRGAGGTCCGRCTTTACCAGA
GCAGCACACTTCCTATCTCGACAT
GGAATAGAGTGGCTTAATTCTCRATC
CCTGTAAGTGCGCYTGCTGRGTTT
CATGGTTGTCACCGATACGGTTGTT
GTACAACAGCAGCCTGAACAAYGAT
CCAGACCGATAACTTTATGACCAAGCG

1.5. Microfluidic systems and their advantages
Since its designation as a distinct area of research by Manz38,39, microfluidics has been seen
as a technology with the potential to achieve better data at faster timescales with only a fraction
of the sample required by traditional methods. Manipulating fluids in channels with features
7

between 1 µm and 100 µm has been applied to a variety of problems. From measuring turgor
pressure in trees, synthesizing pharmaceuticals, to rapidly detecting biomarkers, microfluidics
has excellent potential to make contributions to research on a variety of fronts40–42.
Microfluidic systems possess some inherent advantages when designing advanced
analytical systems. A high surface-area to volume ratio reduces the time required for molecules
to interact with each other. This can be used in a variety of applications, from accelerating small
scale synthesis reactions to capturing targets with immobilized conjugate molecules43,44. Smaller
sample volumes are used than those required for procedures run in a test tube or microcentrifuge
tube, reducing overall waste. Designing automated systems that can detect multiple targets from
a single sample can further simplify the processing needed for accurate rapid detection while also
reducing mistakes attributable to human error.
Other advantages are exemplified in certain types of microfluidic devices. For example, in a
bubble reactor, laminar flows allow 1,000 reactions to be run in parallel without the issue of
cross contamination45. This is a good example of how the flow and mixing of liquids can be
predicted and automated to increase analytical functionality. Centrifugal microfluidics have
conducted four to five step automated immunoassays46. This is a good example of how
microfluidics provides automation, reducing the need of specialized skills or expertise for
conducting biological assays. Additionally, the use of microfluidic components in portable field
equipment has allowed manufacturers to reduce the weight and size to allow such systems to be
carried along for easy analysis in field settings47. Many microfluidic systems can also be
produced at scale, stabilized and shipped around the world. This is ideal for low resource settings
where the infrastructure for expensive diagnostic equipment might not be available. My key
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interest in microfluidics for this project has been in using it as a platform for selectively
concentrating target analytes in preparation for downstream analysis.

1.5.1. Microfluidic analyte preconcentration
From an analytical perspective, one of the most distinct advantages of microfluidics is the
capacity to take trace analytes in a sample and concentrate them down into a smaller volume
fraction before analysis. By modifying channel surfaces, researchers have been able to
concentrate everything from small molecules to E. coli cells, as well as target DNA25,48,49.
Further concentration systems have been created using membranes, electrophoresis, or porous
polymer monoliths modified for specific interactions33,50,51. All these strategies have significantly
improved the limit of detection that can be achieved in a microfluidic setting48,52,53. These
preconcentration systems can also be used as a purification step for downstream analysis,
lowering the background noise and allowing for initial identification followed by downstream
confirmation of drug resistance in bacterial sepsis cases54. For the purposes of DNA analysis,
microfluidic systems that preconcentrate their targets have been coupled to microarrays,
amplification reactions, electrophoresis units, or some form of a solid surface43,55–59.

1.5.2. Magnetic beads
One of the most common preconcentration method uses magnetic beads. With the surface
modified with streptavidin, these beads can be coated with any molecule modified with a
biotin60,61. This system can then be used to pull bound target analyte out of solution, as beads
form a pellet either during centrifugation or in the presence of a magnet62. The streptavidinbiotin bead system provides a good starting point for generating preliminary reference data to

9

compare more experimental conditions against. Some key advantages to bead systems are that
they are well characterized, commercially available, fast to generate, and relatively easy to
implement, for example in a known environment such as test tube pull downs.
It is possible that if packed correctly into a microfluidic device, such beads could provide
additional surface area capable of concentrating the target sequences into a smaller volume.
While extremely low limits of detection have been achieved by assays that utilize magnetic
beads26, the data has usually been acquired on custom made equipment in self-contained systems
that are not designed for commercial production or integration with other complementary
technologies.

1.5.3. Monoliths
A powerful alternative technique for increasing the surface available to pre-concentrate
and purify molecules in a microfluidic device involves the use of porous materials known as
monoliths63,64. These porous structures can be used as synthesized or modified with
biomolecules. A key advantage of monoliths is that their pore structure will resist collapsing
once the polymerization has been terminated63. Additionally, the monolith can be anchored to the
surfaces of glass or polymers, resulting in a porous structure that completely fills the channel and
is anchored to the walls33. This results in the target analyte being forced through the monolith in
a nonlinear torturous path, creating multiple opportunities to interact with immobilized ssDNA.
Some monoliths have been used to purify genomic or plasmid DNA57,65–67, while others have
been used to target specific sequences that were synthesized25,34.
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1.6. General Strategy
By optimizing the capture, labeling, and detection of the sequences identified by the Robison
research group, I planned to create a microfluidic form of Module 2 in Figure 1.1. With this
system, it should be possible to isolate the DNA targets and concentrate them from the products
prepared by Module 1 and prepare them for single-molecule detection analysis in Module 3. This
would represent a significant advance toward using DNA hybridization to capture specific
sequences from drug resistance genes in clinical samples from patients experiencing sepsis to
prepare the DNA for subsequent single molecule counting.
Figure 1.2 illustrates my general strategy for rapidly capturing, labeling, and eluting target
sequences. In brief, the immobilized capture DNA sequences were designed to be hybridized to
their complementary ssDNA at 45 ºC. Non-complementary DNA would be rinsed off before
adding the labeling sequence. After excess label had been rinsed off the monolith, the system
temperature would be raised to above 65 ºC in order to elute the target without disassociating the
full complex. Since both beads and monoliths presented potential utility in acting as a solid
surface for immobilizing the capture strands, both systems were pursued until it became clear
which system would yield more consistent results.

Figure 1.2 Sequence-specific hybridization, labeling and detection. (A) A porous monolith was created with
immobilized DNA sequences complementary to the target. (B) Denatured dsDNA sample was flowed through the
monolith at 5 µL/min. (C) The target DNA hybridized to immobilized DNA while all other sequences were rinsed
away. (D) A >10-fold molar excess of multi-label probe was flowed through the device and then rinsed. (E) The
target-label complex was eluted at 66 °C and detected using fluorescence.
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1.7. Dissertation Overview
If the ability to rapidly diagnose bacterial drug resistance profiles can be developed,
clinicians will have improved ability to treat sepsis by prescribing the correct antibiotic the first
time. It is clear that in the future, disease agents capable of resisting existing antibiotics will
continue to emerge68. This work should help contribute to the effort to develop and perfect the
ability to rapidly diagnose drug resistance.
In chapter 2, I describe the examination of the conditions that were needed to effectively
capture DNA targets via hybridization to complementary strands immobilized to a solid surface.
For this work, I used magnetic beads coated in streptavidin-biotin with coupled capture DNA
sequences. Using these beads, I isolated and measured fluorescently modified DNA targets from
a variety of solutions. I then sought to replicate these experiments in a microfluidic system using
fluorescent microscopy.
In chapter 3, I describe the isolation of sonicated bacterial plasmids that had been captured
from spiked blood samples. I then verified the presence/absence of target sequences via qPCR
before sending said sequences to collaborators at UC Santa Cruz. I present data that provided
confidence that the samples could be used in single particle counting experiments in a
collaborator’s lab.
In chapter 4, I discuss building on the results from chapter 3 by designing a multilabel probe
that can attach to captured target in a sequence-specific manner, a step that could contribute to a
multiplex assay that doesn’t require spatial resolution or multiple sample inputs. I designed a
synthetic polynucleotide that could be labelled with multiple fluorophores. I showed that this
probe could be used to label captured plasmid target in a sequence-specific manner at
concentrations an order of magnitude lower than previously reported.
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In chapter 5, results are summarized, and conclusions presented. Potential improvements and
future directions are also discussed.
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2. FORMULATING CAPTURE BUFFER AND DETERMINING HYBRIDIZATION
EFFICIENCY*
2.1. Introduction
DNA hybridization, microfluidic systems, and single molecule analysis are well-established
fields of study1–4. Integrating these technologies into a viable system is an ongoing present
pursuit. I hypothesized that the conditions for DNA hybridization to be used in a microfluidic
device could be more effectively determined in a series of experiments in microcentrifuge tubes.
There was also the potential that magnetic beads might be a more efficient method for
integrating ssDNA in a microfluidic device than ssDNA modified monoliths since in 2015,
monolith’s required 4-5 days to conduct the steps needed to immobilize ssDNA to their surface.
To determine optimal hybridization conditions, streptavidin-coated beads modified with
biotinylated DNA sequences were used to pull pre-labeled target sequences out of solution. I also
sought to demonstrate that a bead system could be implemented in a microfluidic device.
Magnetic Beads were flowed into a microfluidic device to examine the feasibility of capturing
target DNA via hybridization in an automated system.

2.2. Experimental Section
2.2.1. Material Sources
Commercial oligonucleotides and polynucleotides were purchased from Eurofins Operon
(Louisville, KY). Streptavidin-coated magnetic beads were acquired from New England Biolabs
(Ipswich, MA). Tris HCl hybridization buffer (pH 8) was assembled using the following
reagents: tris(hydrochloride), tris(hydroxymethyl)aminomethane, sodium chloride, and
* Figure 2.4 is adapted with permission from Hanson, Robert L.; Lazalde, Elaine; Knob, Radim;
Harris, David H.; Akuoko, Yesman; Nielsen, Jacob; Woolley, Adam T. Multilabel hybridization
probes for sequence-specific detection of sepsis-related drug resistance genes plasmids. Talanta
Open. 2021, 3, 100034
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magnesium chloride. To prepare monoliths, I used benzoin methyl ether (BME), ethylene
dimethacrylate (EDMA), poly(ethylene glycol)diacrylate (PEGDA, MW 575), 1-dodecanol,
and 2-propanol. All reagents used for buffer and monolith preparation were obtained from either
Sigma-Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA). All chemicals were
analytical grade purity or higher.
Medical grade polypropylene and clear polypropylene sheets were obtained from Great
Basin Corp. (Salt Lake City, UT). Microfluidic connectors used for devices were obtained from
Plaskolite (Columbus, OH), Applied Biosystems (Foster City, CA), and Idex Health & Science
(Bristol, CT. I used a thermoelectric module (VT-31- 1.0-1.3, TE Technology, Traverse City,
MI) operated by a TE Technology controller (TC-48-20). Additionally, control thermistors (MP2444) were purchased for heating.

2.2.2. Capture of Target Sequences In Tube
To assemble the modified magnetic beads that could capture target DNA out of solution,
the following protocol was conducted: 50 µL of magnetic beads at a concentration of 4 mg/mL
was measured into a 250 µL microcentrifuge tube and rinsed by vortexing. The beads were then
immobilized with a magnet while the supernatant was transferred to a fresh tube, and then
resuspended in an equal volume of fresh hybridization buffer. The beads were rinsed 3 times
with 200 µL of hybridization buffer. Initially, the hybridization buffer was composed of 50 mM
NaCl and 20 mM Tris-HCl pH 8.0. After reviewing the literature, I experimented with several
concentrations of NaCl, settling on 500 mM. Then, I experimented with several concentrations of
MgCl2, settling on 50 mM. The final formulation was as follows: 500 mM NaCl, 50 mM MgCl2,
and 20 mM Tris-HCl pH 8.0. 3.5 µL of 10 µM DNA capture sequence stock was added to beads
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and incubated for 30 minutes at room temperature while being agitated. Beads were then rinsed
with 250 µL of capture buffer and stored at 4 °C overnight.
2 µL of DNA target sequence (50 µM aqueous stock solution) was diluted in 200 µL of
hybridization buffer and its fluorescence was measured using a ThermoFisher Nanodrop 3000
(Waltham, MA). This measurement was used to calculate the dilution needed to obtain relative
fluorescence units (RFUs) of 1800-2000. Approximately 250-300 µL of target DNA was
prepared for each sequence condition to be tested.
50 µL of the modified beads (4 mg/µL) were measured into a microcentrifuge tube and
then rinsed 1-3 times with hybridization buffer. The beads were magnetically immobilized, and
the supernatant drawn off. The beads were resuspended in 200 µL of the diluted target sequence.
The samples were then vortexed to mix and incubated for 10 minutes at room temperature on a
rotating agitator. The beads were immobilized, and the supernatant transferred to a tube labeled
fraction ‘A’. The supernatant beads were rinsed by resuspension in another 200 µL of capture
buffer. The rinse was conducted two more times, with the supernatant being placed into fractions
‘B1’, ‘B2’, and ‘B3’ using elution buffer (50 mM MgCl2, and 20 mM Tris-HCl pH 8.0).
All samples were placed into a Cole-Palmer TC 3000 thermocycler (Staffordshire, UK)
and run on the following settings (15 minutes, 85 °C, with the addition of a heated lid). After 7
minutes, the thermocycler was opened, a magnet was used to immobilize the beads and the
supernatant was transferred to a tube labeled fraction ‘C’. This step needed to be completed
within 12 seconds of removing the tube from the thermocycler so that the solution didn’t have
time to cool down. Using 2 µL aliquots of a sample to take a reading on the Nanodrop, five
technical replicates were measured.
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The amount of captured DNA was determined by subtracting the RFU of Fraction ‘A’
from the ‘Starting Concentration’ fraction. The recovered amount was determined by taking an
RFU reading of fraction ‘C’. Capture efficiencies were calculated by dividing the RFU value of
the recovered amount by the RFU value of the starting concentration.

2.2.3. Bead Immobilization in a Microfluidic Device
A circular permanent magnet with a 5 mm radius and a 3 mm thickness was used to
immobilize the beads at a central location in the 500 µm x 500 µm channel within the
microfluidic chip. Beads were diluted and flowed into the chip at ~10 µL/ minute. The location
of the beads was imaged using a charged coupled device (CCD) camera. Elution and capture
were measured using fluorescence induced by a 488 nm laser and collected using a
photomultiplier tube (PMT) linked to LabView software.
For initial hybridization experiments, 200 µL of 1 nM target sequences were captured in-tube
and then flowed into the device. After rinsing for 5 minutes with hybridization buffer, the
magnet was removed, and the resulting peak observed. For later experiments, elution was
performed by leaving the magnet in place, heating the area around the magnet to 65 °C for 2
minutes, and then resuming flow. The last experiments conducted involved sending beads in
first, immobilizing them, and flowing 200 µL of 1 nM pre-labeled DNA target past them,
followed by the elution and detection steps.

2.3. Results and Discussion
The CCD camera showed that when placed in the correct location above the channel, the
magnetic field would hold the bulk of the streptavidin beads in place, pulling them from distant
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locations in the device to a single point, even at 2-3 bar of pressure (Figure 2.1).

Figure 2.1 CCD image of the underside of a microfluidic device. The figure shows bead deposition
in relation to the location of the magnet placed on the top of the device. The circle indicates the
approximate location of the permanent magnet on the topside of the device.

From the fluorescence point detection readout, a single bead would occasionally be swept
past the detection point and seen as a narrow peak that was only a single time point or two in the
readout (data not shown). When the flow was stopped, the magnet removed, and the flow
resumed to flush out beads with attached DNA, the resulting peak was clearly visible. However,
when the capture of targets was run completely in the device by flowing pre-labeled target past
the beads, the resulting peak was considerably smaller, showing little or no capture (Figure 2.2).

Figure 2.2 Fluorescent traces of sequence specific capture. (In Tube) commercially pre-labeled VIM sequences
were captured on magnetic beads and the beads were flowed into the device. The permanent magnet was removed
and the beads flowed past the detection point. (In Channel) Beads were flowed into the microfluidic device and the
fluorescently tagged target sequences flowed past them. The permanent magnet was removed and the beads were
then flowed past the detector.
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Since the peak produced by the in-channel experiment did not match the peak produced
by capturing targets in tube, it was necessary to explain what happened. I hypothesized that the
permanent magnet caused the beads to collapse into a dense plug that did not fill the entire
channel, such that the target sequences could flow around the beads rather than going through
them. When the number of beads was increased to fill the channel completely, the resulting
backpressure of >2 bar during flow was high enough to break the device5. Future work should
focus on dynamically modulating the magnetic beads in a device to enhance capture without high
backpressure.
A definitive outcome from this work was the composition of the hybridization buffer that
maximized the efficiency of capturing target sequences. Many of the factors considered in
hybridization near solid surfaces can be found in the review by Rayan et al 6. My initial
hybridization buffer was composed of Tris-HCl and NaCl. An early result using this initial
formulation indicated that capture efficiency wasn’t affected by the presence of bacterial lysate
as shown in Figure 2.3. Further refinement of the process shifted my measurements from
molarity to percentage RFU and showed a need for improvement. While this formulation could
capture up to 90% of the target sequence from solution, results were often inconsistent (data not
shown).
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Figure 2.3 Concentration of target recovered out of E. coli lysate samples in hybridization buffer that had been
spiked with commercial DNA sequences. t-test yielded a p value of ~0.3 indicating capture was essentially the same
for all conditions.

Bead experiments (see Supplementary Information, Fig. S1) showed that the capture
method worked comparably for a variety of targets. As long as the capture and target sequence
were complementary, hybridization was >75%. By including MgCl2, I improved the efficiency
of target capture up to 96%, with a recovery of 50% (Figure 2.4). I note that this improvement
was only seen when MgCl2 was present around the magnetic beads before they were exposed to
the biotinylated sequences. This is probably because the Mg2+ is critical for minimizing the
repulsion between separate DNA backbones, allowing for more efficient packing of capture
sequences onto each bead.
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Figure 2.4 Efficiency of hybridization capture. (A) Representative experiment using DNA hybridization to capture
and recover target sequences labeled with a single fluorophore. (B) Capture efficiency determined as in (A) for a
variety of target sequences. All unpaired, two tail t-tests yielded a p value <0.01

I also increased the surface area available for capture by increasing the number of beads
used to immobilize an equal amount of capture sequence. This raised the recovery efficiency up
to 70% (Figure 2.5). The relationship is inverse; as more beads are used, fewer capture strands
attach to each single bead. From the technical specifications of NEB magnetic beads, it was
estimated that 1 µg contained 2x106 individual particles. Figure 2.5 shows that recovery is at

% of starting fluorescence

73% near 6,400 µg which converts to ~400 capture sequences per bead.
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Figure 2.5 Efficiency of target recovery with variations in the mass of beads used to hold capture strands. Increasing
amounts of magnetic beads coated in streptavidin were modified with the same concentration of capture sequence
and used to remove target sequence from samples. (Dotted line) Percent captured from solution; (solid line) percent
recovered after elution.
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Of all these conditions, probably the most important for use in later research was the
inclusion of MgCl2 and its various effects on hybridization and labelling efficiency. Thus, I
determined that the formulation of 500 mM NaCl, 50 mM MgCl2 and 20 mM Tris-HCl, pH 8.0
provided the best conditions for efficient hybridization of target sequences. This formulation was
published by Knob et al7. The percent capture during hybridization of multiple different
sequences the capture was >75 % (Fig 2.4)8.

2.4. Conclusion
In this chapter, I demonstrated that it was possible to achieve ~90% capture efficiency by
optimizing the loading of capture sequences on a solid surface and by including MgCl2 in the
hybridization buffer during the stage of bead modification. I further demonstrated that ~70%
recovery of that captured sequence can be achieved by reducing the density of capture sequences
by increasing the number of beads for a given concentration of immobilized biotinylated
sequences. These conditions provide important insight into constructing systems for
pre-concentrating target nucleic acids in microfluidic systems.
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3. SEQUENCE SPECIFIC CAPTURE AND CONCENTRATION OF BACTERIAL
PLASMIDS AS A PRECURSOR TO MULTIPLEX DETECTION USING SINGLE
PARTICLE COUNTING*
3.1. Introduction
A key aspect of my work was to provide samples to the Schmidt research group that were
suitable for analysis using the hollow core anti-resonant reflecting optical waveguides
(ARROWs). Such systems have been demonstrated for detecting multiple fluorescence signals
simultaneously1. My objective was to provide these collaborators with three distinct linearized
plasmid samples that were similar to those seen in real world clinical settings, allowing them to
demonstrate multiplexing capabilities. This would bring the system one step closer to replicating
conditions observed in clinical cases of sepsis2,3, offering the competitive advantage of analyzing
multiple targets in a single sample; thus reducing the required sample volume4,5.
As optimizing hybridization conditions had been successfully completed with synthetic
DNA, I sought to apply those methods to more complicated targets like bacterial plasmids. This
would give my collaborators from the Schmidt research group targets better suited to single
molecule analysis using an ARROW chip and move a step closer to replicating clinical
conditions in the analysis1,6,7. With the limitations posed by using a bead system in a microfluidic
device, I conducted this next set of experiments using DNA that had been immobilized in a
porous polymer monolith.
To avoid the complications associated with working in higher biosafety level environments,
plasmids that only contained the portion of the gene targeted by my immobilized strands and

*

Sections 3.2.1, 3.2.3, and Figure 3.1 of this chapter are adapted with permission from Meena,
G.G.; Hanson, Robert L.; Wood, Ryan L.; Brown, Olivia T.; Stott, Matthew A.; Robison,
Richard A.; Pitt, William G.; Woolley, Adam T.; Hawkins, Aaron R.; Schmidt, Holger. 3x
multiplexed detection of antibiotic resistant plasmids with single molecule sensitivity. Lab Chip.
2020. 20, 3763
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labelling probes were used. This allowed me to conduct relevant experiments at a useful pace
while minimizing the dangers associated with working on drug-resistant pathogens.

3.2. Experimental section
3.2.1. Material sources
Hybridization buffer formulation was the same as described in Chapter 2.2.2. Drug
resistant isolates for KPC, NDM, and VIM were obtained from the Centers for Disease Control
and Intermountain Health Care. Target sequences were amplified and placed in a pUC19
expression vector by the Robison research group. Backup expression vectors with target
sequences were purchased from TwistBioscience (San Francisco, CA).
Qiagen plasmid extraction kits, Sybrgreen master mix, and Taqman master mix were
purchased from ThermoFisher (Waltham, MA). PCR primers were purchased from Integrated
DNA Technologies (San Diego, CA). High fidelity EcoR1 restriction enzyme and competent E.
Coli cells were purchased from New England Biolabs (Ipswich, MA). Ampicillin was purchased
from MilliporeSigma (Burlington, MA). LB broth was provided by Fisherbrand (Santa Clara,
CA). Capture sequences modified with acrydite and an 18-carbon spacer were purchased from
Eurofin Operon (Louisville, KY).

3.2.2. Plasmid design
To reduce the danger of our experiments to an appropriate biosafety level, portions of the
genes containing target sequences but not the whole genes were amplified from clinical isolates
and then spliced into a pUC19 plasmid vector that could be kept inside nascent E. coli cells at 80 °C until they were needed.
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The initial KPC target sequence was placed at a location that would require over 300
bases of the plasmid to move out of the way in order for hybridization with the capture strand to
occur. In the commercial backup plasmids I moved the EcoR1 cut site within 30 bases of the
target hybridization site. The point where the labelling probe would start hybridization to
captured target strands were located 47 bp downstream from the target hybridization site.

3.2.3. Plasmid preparation
Two types of DNA samples were generated for use in these experiments. For the first
type, E. coli cells containing the plasmid were grown in LB broth containing ampicillin to select
for the presence of plasmids containing the target sequence. The Qiagen plasmid extraction
protocol was conducted with the following modifications: Each solid phase column had two
volumes of plasmid extraction run through it, and 5-6 columns were used for each sequence.
Plasmid was eluted in 7-10 µL volumes. The eluates for each target sequence were pooled to
give 42-60 µL of high-concentration target to use as stock.
The second type of sample was grown up in ampicillin-selective LB broth and the
plasmid captured according to methods used by the Pitt engineering group and published by
Meena et al8. In brief, these plasmid samples were captured using a microfluidic bead system and
sonicate to produce DNA fragments.
The enzyme linearized stock was used to run prototyping experiments in parallel with
sonicated samples that would allow for more rapid analysis times. All samples were stored at 4
°C in Tris-EDTA for no more than 7 days to avoid enzymatic degradation.
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3.2.4. Monolith preparation
Monoliths were generated using the method published by Knob et al9. In brief, the
following formulation was used to assemble the porous monoliths with immobilized DNA: 3 mg
betamercaptoethanol, 47 mg dodecanol, 10 mg of DNA resuspended in 50/50 isopropyl alcohol
(IPA)/H2O, 15 mg IPA, 20 mg ethylenedimethylacrylate (EDMA), 20 mg polyethylene glycol
diacrylate (PEGDA). After all reagents were pipetted into a 300 µL microcentrifuge tube, the
solution was then vortexed to ensure thorough homogenization.
The procedure used to fabricate devices was adapted from the one described by Knob10.
In brief, an aluminum stamp machined with channel features was pressed into a piece of
polypropylene using a heated press set to 160 °C. After the stamp had been removed, access
ports were drilled through the device and the device was sealed with a clear 2mm piece of
polypropylene using a heated press set to 148 °C. Loctite resin (Henkel, Düsseldorf
Germany) was used to attach connecting port (IDEX, Oak Harbor, Washington, USA).
The 5 mm polymerization window was created using black electrical tape to act as a mask.
Solution was then drawn into the device via capillary action through the pin extending from the
outlet. The device was placed under the 600 UV lamp (Uvitron International, West Springfield,
MA) set at ½ power for 12 minutes, removed, flipped and allowed to sit for 5 minutes before
rinsing with 100 µL of IPA followed by a rinse with 100 µL of H2O. The monoliths were then
allowed to sit overnight in water before running experiments the next day.

3.2.5. Monolith analysis
Monoliths were analyzed post experiment by scanning electron microscopy (SEM) imaging
to confirm porosity and attachment to the channel walls. To do this, the device was warmed in a
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90 °C oven for 5 minutes and the section of channel containing the monolith was cut out using a
razor. After trimming away the excess polypropylene, 2-3 mm cross sections of the channel were
sliced and placed on a circular platform using double-sided tape to secure them. A layer of
palladium/gold alloy was deposited over the monoliths for 60 seconds, to reduce image distortion
due to surface charging in the SEM. The cross sections were then imaged using the Helios
Nanolab 600 FEI scanning electron microscope (Hillsboro, OR). Images were analyzed using
ImageJ software to take measurements of nodes and pores.

3.2.6. Sequence-selective capture
UV/Vis 1000 Nanodrop readings of plasmid cut with EcoRI restriction enzyme gave a
concentration measurement in ng/µL (ThermoFisher, Waltham, MA). A dilution series was then
performed to generate 250 µL of 10 nM plasmid. 200 µL of this solution flowed into a device
while heater 2 (Figure 3.1) was set at 85 °C to denature the DNA and allow the ssDNA to
hybridize to the immobilized capture strands on the monolith while heater 1 (Figure 3.1) was set
at 45 °C. An additional 200 µL of hybridization buffer was flowed through the device while
heater 2 was still set at 85 °C to ensure that no target was lost in the dead volume. Heater 2 was
then turned off.
At this point, one of two steps was taken. If the sample was going to be analyzed via
fluorescence for capture, then complementary hybridization probe modified with two fluorescein
molecules was flowed in and allowed to hybridize to the captured plasmid. The excess was then
rinsed until PMT fluorescence returned to background and the flow was then stopped. Heater 1,
above the monolith, was set to 65 °C for 2 minutes. Then the flow was resumed, and the
resulting peak recorded. If the samples were going to be shipped to UC Santa Cruz for single
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molecule analysis, the labeling step was skipped and the eluate was simply captured and divided
for qPCR and single molecule analysis. Positive and negative controls using synthesized
fluorescently labeled sequences were performed after experimental samples to avoid cross
contamination.

3.2.7. qPCR validation and shipment
The pressure exerted by the pump was adjusted until the flow meter gave a consistent reading
of 5 µL/min. At this point, the flow meter was disconnected from the microfluidic device to
allow the collection of eluate for subsequent qPCR analysis. Flowthrough was collected in ~30
µL fractions that were split between two sets of tubes. 12-15 µL was saved for qPCR analysis,
and 12-15 µL was placed on dry ice to ship to the School of Engineering at UC Santa Cruz. Each
fraction was analyzed by Sybrgreen qPCR using the QuantStudio 5 platform (Applied
Biosystems, Waltham MA). Samples that showed a high cT value before elution, followed by a
lower cT value after the 65 °C elution step were designated as suitable for multiplex analysis by
the Schmidt research group. Negative qPCR controls included reaction with no template DNA,
and another reaction with mismatched primers. Positive controls were performed using an
aliquot of the stock plasmid.

3.3. Results and Discussion
Photographs of a fabricated device were taken before cutting cross sections that could be
subsequently analyzed via SEM (Figure 3.1). In panel A of Figure 3.1, it can be seen that
channel and monolith maintained their macroscopic integrity throughout the procedure. Post
experimental SEM scans allowed me to evaluate the porosity and shape of the monolith used to
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immobilized capture sequences. Figure 3.1 B shows the sealing process slightly deformed the
channel, but the monolith was able to fill in the gaps and adhere strongly enough to the sides to
force the target DNA to flow-through the monolith rather than around it. From evaluating
multiple images like those in Figure 3.1 C, nodule size was determined to be 1.2±0.2 µm and
pore size was 2±0.4 µm (n=6). Efficiency of capture was estimated using the qPCR cT values of
the flow-through solution compared to an aliquot of the starting solution. It was estimated that
67.3 % of the DNA flowed through the device was captured and eluted in 30 µL.

Figure 3.1 Monolith properties and location of features within a microfluidic device. (a) Bottom-up view of the
device (b) SEM image of monolith cross section; (c) zoomed in view of cross section; nodule size was 1.2±0.2 μm
and pore size was 2.0 ± 0.4 μm (n=6).

A complication emerged with detecting successful capture and elution of target samples
before sending them to UCSC. An analysis of samples labeled at BYU compared to those labeled
at UCSC via ARROW chip (Figure 3.2) showed that the same concentration of DNA yielded
different amounts of signal. As seen by the differences in the y-axis of panel A in Figure 3.2, It is
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A

Figure 3.2 Single molecule analysis of DNA sequences labeled with 2-flourescein probe. (a) Sample labeled on site.
(b) Sample was labeled at BYU, frozen, and shipped to UCSC.

clear that the sequences that were labeled at UCSC produced significantly more signals that rose
above the noise threshold. This is clearly a superior result when compared to the signals
produced by the sequences that were labeled and then shipped to UCSC since the signals that rise
above the noise threshold are at least an order of magnitude lower. It was assumed that this could
have resulted from a mismatch between the two technologies, since the concentrations of sample
useful to the Schmidt group were significantly lower than the limit of detection that my
fluorescence microscope system could achieve. Thus, when working at the appropriate trace
concentrations of DNA in the monolith system it would be difficult to know for certain that a
procedure had successfully yielded a high-quality sample relying on the fluorescent readout
alone. To bridge this technology gap, I opted to use qPCR to assess the samples before shipping.
Additionally, I found that by collecting all the flow-through and comparing the cT
values, it was possible to gain greater insights into the interactions that were occurring in the
microfluidic device. Figure 3.3 panel A contains the laser-induced fluorescence trace collected
by PMT placed over the qPCR cT values of the flow-through fractions collected from the device.
The cT values produced by qPCR have an inverse relationship to starting DNA concentration.
By examining where the cT value was lower, it is possible to infer the events of target being
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captured (Figure 3.3, fraction 1-2), excess target breaking through the monolith (Figure 3.3,
fraction 3-4), captured target staying in place as it is being labeled (Figure 3.3, fraction 5-10),
and then having the target eluted in a concentrated volume (Figure 3.3, fraction 11-14). The
increase in DNA concentration coming off the device indicated by the drop in cT value between
fractions 10 and 11 combined the with the fluorescent peak observed in the PMT trace gave me
confidence that the completely assembled fluorescent complex had labeled the NDM target in a
sequence-specific manner, had been eluted, and was of suitable quality for Schmidt’s research
group. The qPCR method proved reliable enough that I used it in place of fluorescence detection
when I prepared samples containing trace concentrations of target for UCSC.
After conducting several concentration procedures, an aliquot of stock plasmid was taken
and a series of 1:10 dilutions (aliquot:H2O) were performed to create a calibration curve (Figure
3.3 panel B). These cT values were used to convert the cT values of the experimental sample to
molar concentrations of the target. A comparison of a representative sample’s eluate to the
starting concentration loaded onto the monolith showed a capture efficiency of ~63%.
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Figure 3.3 Comparison of qPCR cT values for capture and elution of plasmid targets.
(A) PMT trace of capture and elution along with cT values generated by qPCR performed on the collected
flowthrough. (B) Calibration curve of VIM plasmid sequence generated using dilutions taken from VIM plasmid
before it was loaded into the microfluidic chip.

When preparing samples for the Schmidt group, multiple fractions were collected
following elution to ensure that the portion of flowthrough containing the highest concentration
of captured target was not diluted or missed. The specific cT values for each sequence before and
after heated elution were recorded in Table 3.1. This allowed me to ship to Santa Cruz three
plasmid samples that had each been captured and concentrated in a sequence-specific manner.
The subsequent multiplexed single-molecule analysis done on these samples was recently
published8.

40

Table 3.1 cT values of three 30 µL aliquots collected following the resumption of flow after heating. Samples that
demonstrated a drop in cT value were considered suitable to be shipped to UC Santa Cruz for single molecule analysis.
Undetected means signal did not rise above threshold.

NDM plasmid
sonicated
VIM plasmid sonicated
KPC plasmid sonicated
KPC negative control
KPC positive control

Pre-elution
Undetected
Undetected
18.8
28.5

Elution
Heating (65 °C, 2min)

Target

14.3

13.4

16.7

20.5

16.0

19.5

23.6

14.5

13.9

16.9

31.5

31.5

29.1

12.3

12.5

12.6

3.4. Conclusions
One of the features of this method that leaves room for improvement involves labelling and
detection of the targets. Because the labels used in the multiplex experiment were applied after
shipment to Santa Cruz, it can only be said that the targets were concentrated in a sequencespecific manner and not labeled in a sequence specific manner. Since sequence-specific labelling
is an important step for avoiding false positives in a point-of-care test, this is a step that will need
to be demonstrated in future work if this is method is to be incorporated into a final platform.
The next chapter demonstrates one potential solution to this issue.
Another step that would require future improvements lies in the incorporation of DNA
into the porous polymer monolith. These current experiments required that the monolith stay
completely immersed in aqueous solution to maintain its hybridization ability. Such a
requirement may pose a problem for chips that need to be kept in long-term storage.
Theoretically, shelf life could be extended if the monolith could be lyophilized without
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separation from the channel walls or denaturing the DNA. It would also be necessary to
rehydrate the monolith in a way that prevents air bubbles from being trapped in the monolith,
since that would interfere with downstream analytical steps.
The fragmentation of plasmids using sonication poses a tradeoff between reproducibility
and speed that needs to be carefully considered11–13. While speed is critical to the usefulness of
the method, if the target sequence is consistently cleaved then the tradeoff is no longer an
advantage. Some alternative methods of getting sequence-specific targets include truncated
polymerase chain reaction (PCR) of 20 minutes or less, or restriction enzymes. However, neither
of the two options provides a completely satisfactory alternative to the dilemma. Restriction
enzymes are slower and less agile, but also provide more uniform fragments. In contrast, using
any form of PCR removes the advantages conferred by sidestepping amplification processes.
Since many publications on hybridization use oligonucleotide targets that are only a few
hundreds of base pairs, this research is useful in showing that it is possible to capture and
specifically label larger plasmid targets14–17. The cell isolation, DNA extraction methods, and
multiplexing results published by Wood et al.18 and Meena et al.8 show great promise in creating
platforms that are capable of obtaining information on multiple targets, reducing sample size and
time to answer.
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4. MULTILABEL HYBRIDIZATION PROBES FOR SEQUENCE-SPECIFIC
DETECTION OF SEPSIS-RELATED DRUG RESISTANCE GENES IN PLASMIDS*
4.1. Introduction
Sepsis is an increasing global concern, as emerging antimicrobial drug-resistant strains of
bacteria have changed this disease from a treatable inconvenience to a life-threatening condition
that doctors cannot easily address 1,2. The threat posed by sepsis could be reduced if doctors had
an accurate determination of bacterial drug resistance within the necessary window of time to
begin administering medication 3,4.
Current technologies used in clinical settings, such as blood culture or PCR, usually
involve some form of purifying and copying existing targets before the analysis step in order to
increase the quantity of analyte to a level above the limit of detection. This amplification step is
usually the most time-consuming part of the process. Digital qPCR shows considerable promise
in achieving low limits of detection, but most modalities are still sensitive to the presence of
background bacteria and thus require sample cleanup to confer sufficient robustness to be
commercially viable 5,6. Two technologies that together could potentially address this gap
without needing amplification are single-molecule detection 7, and microfluidic or point of care
(POC) devices 8–10.
It is possible to raise signal without amplification by selectively capturing a target analyte
as it passes over a surface modified with an appropriate conjugate. Such conjugates can be
antibodies, hydrophobic carbon chains, or complementary DNA that hybridize to the target by
virtue of its sequence 11–16. As capture results in the target being concentrated into a smaller

*Chapter 4 is adapted with permission from Hanson, Robert L.; Lazalde, Elaine; Knob, Radim;
Harris, David H.; Akuoko, Yesman; Nielsen, Jacob; Woolley, Adam T. Multilabel hybridization
probes for sequence-specific detection of sepsis-related drug resistance genes plasmids. Talanta
Open. 2021, 3, 100034
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volume upon elution, signal may be increased significantly 17. A strategy of DNA hybridization
is particularly attractive for detecting genes related to drug resistance because off-target DNA
sequences will be omited, along with other contaminating molecules from a blood sample 9,18–20.
Recent publications have shown that it is possible to achieve rapid detection of very low
concentrations of target DNA sequences through single-molecule detection methods 21,22.
However, some challenges remain to be addressed when integrating these approaches with
common biology workflows. Total internal fluorescence detection systems can count individual
molecules with detection limits in the mid-fM range; however, this detection can be difficult to
implement at larger scales due to specialized and costly equipment 23. Additionally, the needed
surface immobilization of detected molecules can introduce difficulties for multiplexed
downstream procedures. In contrast, flow-through systems can be readily linked to downstream
analysis, but require high signal for each molecule to be detected. Such results are typically
achieved by associating a large number of fluorophores with the desired target molecule. Thus,
for single-molecule detection, the best results are obtained from large targets, typically in the
kilobase size range for nucleic acids, that are labeled with a sufficient number of fluorophores 24–
26

. Although this approach provides high signal, it hasn’t seen widespread adoption into

microfluidic or POC technologies because of the challenges associated with hybridization of
long DNA targets. Many biology laboratory methods work better with much shorter DNA target
sequences with lengths of a few hundred bp or less 13,27,28. Such issues prevent single-molecule
fluorescent counting from easily being applied to a number of nucleic acid related problems that
could benefit from sequence-specific labeling and superior limits of detection.
One possible solution is to keep the length of a DNA target small, while increasing the
amount of fluorescent label attached to the probe that labels each target. Exemplary work has
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been done in this area using a variety of methods, mainly to improve processes that utilize
amplification or that are conducted in test tubes in a highly technical setting 7,29–33. Luminescent
quantum dots have also been used to increase signal but the toxicity of Cd cores has led to a
search for safer alternatives, whose detection capabilities are not as well characterized 34. I have
thus focused on creating a simple multi-label probe that can label short nucleic acid targets in a
sequence-specific manner as a step toward a POC system that would utilize single-molecule
detection as an alternative to sample amplification to achieve low limits of detection.
Figure 4.1 gives a schematic overview of the approach. Briefly, a capture sequence of
ssDNA modified with acrydite was immobilized by incorporating it into a porous acrylate
polymer monolith (Figure 4.1A). A denatured plasmid sample was then flowed through the
monolith and allowed to hybridize while non-complementary sequences would simply pass
through the monolith, as shown in Figure 4.1B and C. After sufficient rinsing, a multi-labeled
probe with complementary sequence was used to label the captured target (Figure 4.1D). A final
rinse was followed by heating at 65 ºC to release the complex for fluorescence detection (Figure
4.1E). My simple labeling approach places multiple SYBR Gold fluorophores on each
individual probe, that has a 25 bp protruding segment ssDNA which can hybridize sequencespecifically, to detect a bacterial plasmid containing a portion of the New Dehli metallo-beta
lactamase (NDM) gene that can confer drug resistance in sepsis cases. This provides a
foundation for developing amplification-free detection of shorter nucleic acid sequences related
to drug resistance in sepsis.
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Figure 4.1 Sequence-specific hybridization, labeling and detection. (A) A porous monolith was created with
immobilized DNA sequences complementary to the target. (B) Denatured dsDNA sample was flowed through the
monolith. (C) The target DNA hybridized to immobilized DNA while all other sequences were rinsed away. (D) A
>10-fold molar excess of multi-label probe was flowed through the device and then rinsed. (E) The target-label
complex was eluted at 66 °C and detected using fluorescence.

4.2. Experimental Section
4.2.1. Material Sources
Polypropylene for device fabrication was obtained from Great Basin Corp. (Salt Lake
City, UT). To control temperature on devices, a VT-31-1.0-1.3 system by TE technology
(Traverse City, MI) operated by their controller (TC-48-20) and thermistors (MP-2444) was
used.
Unless otherwise stated, chemicals were purchased from Sigma-Aldrich (St. Louis, MO)
or Fisher Scientific (Pittsburgh, PA). All chemicals were at least analytical grade purity. The
acrylate monolith containing immobilized ssDNA for hybridization was made with the following
chemicals: poly(ethyleneglycol)diacrylate (PEGDA) MW 575, ethylenedimethacrylate (EDMA),
isopropyl alcohol (IPA), and acrydite-modified DNA polynucleotides (Eurofins Louisville, KY)
suspended in a 50/50 mixture of H2O/IPA, and 1-dodecanol.
Tris(hydrochloride), tris (hydroxymethyl) aminomethane, magnesium chloride, and sodium
chloride were used to create a hybridization buffer consisting of 20 mM Tris HCl, pH 8.0, with
50 mM MgCl2 and 500 mM NaCl. The resulting solution was pushed through a filter to remove
any particulates. For final experiments, a 6.7X concentrated version of this buffer was made to
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allow mixing with water and DNA stock while avoiding unwanted dilution. For generating the
multilabel probe, a labeling buffer was created by omitting NaCl from the hybridization buffer to
increase the strength of SYBR Gold binding.

4.2.2. Sample Selection and Preparation
DNA plasmid targets were generated using methods from previous work 21. In brief, E.
coli containing the target plasmid were grown in lysogeny broth (LB) containing ampicillin. The
DNA was then extracted using a Qiagen (Germantown, MD) DNA extraction kit with a modified
protocol. The key changes involved loading samples from multiple extractions onto a single
solid-phase column and eluting in a small volume to maximize DNA content of the sample
before dilution. The plasmid was then linearized using EcoR1 restriction enzyme (New England
Biolabs, Ipswich, MA). This concentrated stock plasmid solution’s concentration was confirmed
by Nanodrop 1000 UV/vis absorbance (Thermo-Fisher, Waltham, MA). The sample was stored
at 4 ºC until use. Dilution series solutions were prepared by careful dilution of this stock. A
plasmid containing a portion of the NDM gene sequence was used as the target, whereas a
plasmid containing part of the KPC gene sequence was used for negative control experiments.
NDM was selected for further experimentation due to its prevalence in anti-microbial drug
resistance cases.
To prepare the labeling probe, the polynucleotide was captured on streptavidin-coated
beads modified with the complementary sequence (New England Biolabs). The capture, target
and probe sequences are given in Table 4.1. A second piece of 77 bp DNA was added to make
the suspended sequence double-stranded. After rinsing 4 times with labeling buffer, a 20 µL
aliquot was taken and used to estimate the amount of DNA captured by the beads by taking 5
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technical replicates on a Nanodrop 1000. This amount was used to calculate the concentration of
SYBR Gold dye (Thermo-Fisher) to be used to label the probe. The probe was then resuspended
in solution with the appropriate amount of SYBR Gold dye and agitated for ~15 min at room
temperature. The excess dye was rinsed off 6 times, and the tubes placed on a 66 ºC heat block
for 5 min. A magnet was used to immobilize the beads and transfer the supernatant containing
the probe into a fresh tube. Fluorescence was evaluated by taking 5 technical replicates on a
Thermo-Fisher Nanodrop 3000.
Table 4.1 Sequences for capture and labeling target sequences with multilabel probe. Sequences are given 5’to 3’;
capture sequence and complement are underlined, and probe and hybridization sequences are in bold font.

Sequence description

Sequence

Capture sequence

[5acrd]GCAGCACACTTCCTATCTCGACAT

Target in plasmid

CCGCCATCCCTGACGATCAAACCGTTGGAAGCG
ACTGCCCCGAAACCCGGCATGTCGAGATAGGAAG
TGTGCTGCGAATTCGT

Probe

CAGTCGCTTCCAACGGTTTGATCGTCAGGGATG
GCGGCCGCGTGCTGGTGGTCGATACCGCCTGGACC
GATGACCAGACCGCCCAGATCCTCAACTGGATCA
AGCAGGAGATCAACCTGC

4.2.3. Monolith Preparation and Experimental Conditions
The general device preparation process is described by Knob 9. In brief, an aluminum
stamp was used to imprint channel features into polypropylene at 160 ºC. After the stamp was
removed and access holes created, the device was sealed by pressing a 2 mm clear film of
polypropylene (Great Basin Corp.) over the channels at 148 ºC. Loctite resin #1360788 (Henkel,
Düsseldorf, Germany) was used to attach connecting ports and ensure complete sealing of the
device.
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The monolith was created using the same formulation as used by Knob et al. 9, with a few
minor changes. Specifically, after removing the device from the UV lamp the device was flipped
over and allowed to sit for 5 min post-polymerization before rinsing with 100 µL of IPA and
then 1000 µL of H2O at ~5 µL/min using a Fluigent system (Lowell, MA). Devices were stored
with H2O in the channels until they were used.

4.2.4. Device Operation
Melt curve analysis (Figure 4.2) demonstrated that ~83 °C was sufficient for denaturation
of a 2-3 kbp plasmid, indicating that the operating parameters selected for the system should
allow for the capture of target sequences from double-stranded DNA as it was loaded into the
chip.

Figure 4.2 Melt curve analysis of amplified plasmid samples. The plasmid targets denatured at ~83 °C.
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General device operation is described in Knob9. Devices were designed to have two fluid
inputs. The sample channel (Figure. 4.3A, light blue) was given a series of curves to increase the
channel length in the denaturing heater zone, allowing denaturation to facilitate subsequent
hybridization to the capture sequence on the monolith.

Figure 4.3 Device layout and characterization. (A) Device layout schematic showing sample loading channel (light
blue), labeling channel (green), monolith (purple) and detection point (dark blue). Heaters were placed on top of the
sections outlined in red. (B) Photograph of a device. (C) Channel-view SEM. (D)

The probe channel (Figure 4.3A, green) was designed to be shorter to minimize the
volume needed to flush out the fluorescent probe used. The monolith formed in the channel
(Figure 4.3A, purple) was placed under a heater located as indicated in Fig. 4.3A prior to the
laser-induced fluorescence detection point (Figure. 4.3A, dark blue).
The fluorescece microscope system used for analyzing capture and elution was described
by Knob et al 19. In brief, a 488 nm laser was focused on a spot in the sample channel ~3 mm
after the end of the monolith. The resulting fluorescence was detected using a photomultiplier
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tube (PMT) with the signal recorded using LabView (National Instruments, Austin, TX) software
and boxcar averaging to filter high-frequency noise.
All controls and experimental samples were run with the following method. To create a
sample for the experiment, I diluted stock target to create 100-200 µL of sample at the desired
concentration in hybridization buffer. Then, 120 µL of sample was transferred to a loading tube
attached to the Fluigent reservoirs. The sample denaturing heater (see Figure 4.3A for
configuration) was set to 85 ºC, the hybridization heater set to 45 ºC, and the pressure on the
sample channel set to 300 mbar. The pressure was adjusted to maintain a flow rate of ~5 µL/min.
After flowing 100 µL of sample the tube was replaced with one containing hybridization buffer.
The flow was resumed and 200 µL of solution allowed to flow into the chip, after which flow
through the sample channel was stopped. Next, ~300 mbar was applied to the probe channel (see
Figure 4.3A for configuration) and 100 µL of hybridization probe was flowed through the
monolith. Then, hybridization buffer was flowed through both the sample and probe channel,
alternating back and forth, until the observed fluorescence returned to background. At this point,
the flow was stopped, and the hybridization heater was set to 65 ºC for 2 min. Finally, the flow
was re-engaged, and ~100 µL was allowed to flow past the detection point. Fluorescence
detection with a focused laser under flow conditions limits the time any fluorophore spends in
the excitation volume, thus reducing problems associated with photobleaching. The elution
volume was estimated from the collected amount to be ~20 µL.
Experimental samples were run starting with the lowest concentration and progressing to the
highest (1 nM) concentration, and a negative control was run after experimental samples.
Baselines were normalized to the baseline observed in the negative control. Peak areas and
heights were calculated after baseline subtraction using in-house-written MATLAB code 35.
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4.3. Results and Discussion
The monolith device schematics and features are shown in Figure 4.3. A photograph of the
underside of the device (Figure 4.3B) shows the device, with the sample channel being ~60 mm
and the probe channel being ~10 mm long. The monolith, located above the detection point, is
slightly longer than the 5 mm window in the mask, probably due to light scatter or diffusion of
reactive species during polymerization. To assess the porosity of the capture DNA monoliths,
SEMs were taken of 2-mm-thick cross section slices of the channel (Figure 4.3C-D). The
monolith filled the entire channel and was attached to the walls of the device as seen in Figure
4.3C. The average pore size was 0.51 ± 0.011 µm (n=6) and the average nodule size was 0.63 ±
0.0077 µm (n=6). The resulting monoliths would allow sample to flow through the device at 5
µL/min at 45 °C with 300 mbar of positive pressure. Over the course of this study, 8 complete
devices were made, with data from 4 devices appearing in the figures. A decision not to use a
device was made if flow rates were too fast or slow. Post-analysis of these non-used devices
often showed poor attachment of monolith to the channel walls, or regions of dense non-porous
monolith (data not shown).
Because SYBR Gold’s formulation is proprietary
(https://www.thermofisher.com/order/catalog/product/S11494#/S11494), estimating dye
concentration is challenging. The information provided indicates that the stock concentration is
10,000 times greater than the running concentration. To make a comparison to a known sample, I
ran several empirical experiments. In my final procedure, aliquots of captured DNA were labeled
in a microcentrifuge tube with a traditional probe or a multilabel probe and assessed via
Nanodrop fluorescence (Figure. 4.4). The readings show that the multilabel probe system
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produces a signal that is ~3 times greater than that produced by the same molar concentration of
probes labeled with a single fluorescein.

Figure 4.4 Comparison of fluorescence after elution of captured DNA labeled with either single or multilabel
fluorescent hybridization probes. In tubes, aliquots of captured target were labeled with either a traditional or
multilabeled probe. The resulting solutions were examined via a Nanodrop 3000 spectrometer to compare the
difference in fluorescence between the two conditions. The error bars represent ±1 standard deviation. A t-test
yielded a p value <0.01.

By this, I determined that 1.5 µM 120-mer probe (with 77 bp of dsDNA content) formed in
450 µL of 1/3X SYBR Gold yielded fluorescence approximately three times greater than that of
1.5 µM of a synthetic DNA sequence labeled with a single fluorescein. However, a direct
comparison of fluorophore fluorescence cannot be made between these two measurements
because the exact molarity of SYBR Gold is unknown. Because my labeling concentration was
3X lower than that recommended by the manufacturer, I expect labeling in the probe to be such
that the spacing between molecules will be large enough to limit self-quenching. If the multilabel
probe was created under different conditions, such as with a brighter signaling molecule or a
longer polynucleotide, the observed increase in fluorescence would likely be even greater. I also
carried out a negative control wherein I compared the fluorescence after bead capture of NDM or
KPC plasmid and labeling with the NDM multilabel probe (Figure 4.5). This experiment showed
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significantly lower fluorescence when the NDM multilabel probe was used in conjunction with
the KPC plasmid, indicating good specificity and low levels of fluorescent dye transfer from the
multilabel probe. This result confirms selective capture and fluorescent labeling of bacterial
plasmid containing our target sequence, providing general conditions for labeling disease-related
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Figure 4.5 Negative control to assess nonspecific labeling of off-target sequences. (Negative control) Fluorescence
resulting from biotinylated KPC sequence attached after exposure to NDM multilabel probe. (Multilabel)
Fluorescence resulting from NDM plasmid after labeling with the NDM multilabel probe. The error bars are ± 1
standard deviation. A t-test yielded a p-value of <0.01.

I used the multilabel fluorescent probes in detecting plasmid DNA purified using a monolith
column. The plot in Figure 4.6 shows the capture (10-20 min), rinsing (20-45 min), labeling (4555 min), rinsing (55-68 min), heating (68-70 min), and elution (>70 min) of a bacterial plasmid
target in the system. The observed fluorescence (Figure 4.6, black line) shows peaks in response
to key events in the capture and detection of the target. During the first 20 min, the unlabeled
plasmid target is denatured via heat and flowed through the monolith to capture and concentrate
it, followed by rinsing. The large peak in fluorescence at 50 min indicates column bleed-through
of labeling probe, indicating that we used enough fluorescent probe to label all the captured
56

plasmid DNA, with excess flowing through the monolith. The second peak at 65 min results
from switching the flow to remove any label remaining in the dead volume of the probe channel
during the labeling step. The sharp peak at 70 minutes is the result of the labeled target/probe
complex being eluted and flowing past the detection point.

Figure 4.6 Fluorescence after the monolith during loading, labeling, rinsing and elution. The temperature profiles at
the sample denaturation and elution heaters are also plotted. Heater 1 controlled the temperature of capture and
elution on the monolith and heater 2 controlled the temperature that denatured the target sample.
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Repeated analyses of 1 pM target samples (see Fig. 4.7) yielded an average, baseline
subtracted peak height of 0.18 ± 0.03 (n=3), showing good device repeatability for multiple
experiments.

Figure 4.7 Replicate fluorescence results during elution. One pM plasmid (or a negative control) was captured on a
monolith and labeled with the multi-fluorophore probe.

I also carried out multiple capture experiments with different plasmid concentrations to
evaluate those effects (Figure 4.8). Some tailing was observed in the elution peaks; this could
possibly be due to minor temperature variations across the monolith during the denaturing step,
resulting in variability in captured DNA release when flow was re-initiated. Because of this
tailing, I used peak height rather than area as the parameter to compare between runs. To better
compare peak heights, baselines were set to zero at 120 s post-heating using in-house Matlab
code. I observed a linear relationship between concentration and eluted peak height from 1 pM to
1 nM, with the resulting linear fit having the equation: y = 0.00036x + 0.17, R² = 0.98.
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Experiments done on samples with concentrations <1 pM no longer followed this linear trend
(data not shown), resulting in a ~1 pM minimum concentration detected, as my setup is presently
constituted. This result compares favorably with the 30 pM limit of detection that was recently
obtained by our research group for analysis of bacterial plasmids with single-fluorophore probe
labeling35 and is also competitive with current methods for low levels of detection without
amplification 17,30,36. A colleague had previously measured the percent recovery of target in these
flow through devices, which ranged from as low as a few percent for ~nM concentrations 9 to
>80% for 1 pM target concentrations 19, such as those detected herein.

Figure 4.8 Fluorescence during elution for different concentrations of loaded target labeled with the multifluorophore probe. (A) Fluorescence of different concentrations during elution. (B) Plot of eluted peak height as a
function of concentration. (inset) Magnified comparison of error bars that depict ± 1 standard deviation of the
baseline signal.

The time of the procedure could be significantly shortened if the rinse times could be
reduced. This might be accomplished by tuning the amount of hybridization probe used to avoid
introducing excess label while still saturating captured DNA on the monolith. Future work
should include an additional measurement taken around 500 pM to avoid the statistical bias that
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results from a lone high concentration sample. Further improvements to the limit of detection
may be possible by increasing the length of the hybridization probe beyond the 120 bases
currently used. To avoid the potential for the non-covalently attached fluorophores to
spontaneously and nonspecifically transfer to different strands of DNA, in the future it could be
valuable to develop probes using DNA monomers that have been covalently attached to
fluorophores and then assembled by PCR 37,38. Previous labeling systems similar to mine were
created using shorter polynucleotides, and had detection limits in the low nM range 39–41. A more
recent approach involved post-synthesis modification of DNA, achieving detection limits of ~10
pM 42. If these methods can be extended to longer polynucleotides they may be able to approach
the 1 pM target detection levels I show here.

4.4. Conclusions
In this work, I have demonstrated that it is possible to create enhanced fluorescent
hybridization probes with at least 3-fold greater fluorescence than a single labeled fluorophore.
Furthermore, these probes can be reliably used to label bacterial plasmid targets that have been
concentrated on a solid support in a flow through microfluidic device. Both capture and labeling
are done in a sequence-specific manner. Signal from eluted targets that had been captured on the
solid support varied linearly with input plasmid concentration from 1 pM to 1 nM.
This method can be used to increase fluorescent signal from shorter DNA targets, potentially
enabling their detection using single-particle counting 21,43,44. Such implementation with singlemolecule analysis methods might also improve limits of detection to allow direct, amplificationfree determination of nucleic acid targets. Combined with other advances in bacterial sample
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preparation 45,46, this could provide a promising approach for rapidly analyzing antibioticresistant bacteria related to sepsis.
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5. CONCLUSIONS AND FUTURE WORK

5.1. Summary
Each of the preceding chapters constitutes a significant step towards the goal of a system
that can label DNA targets in a sequence-specific manner. First, I optimized the concentrations
of the buffer used for DNA hybridization experiments and noted the key step of implementing
this buffer’s use when allowing the biotinylated DNA to attach to the magnetic beads. This
allowed me to pull target sequences out of solution, label them, and elute them for analysis
within 30 minutes.
In chapter 3, I showed how this buffer could be used to concentrate linearized bacterial
plasmid containing a target sequence and then send that concentrated sample to Prof. Schmidt’s
optics research group for multiplex analysis. This demonstrated that steps for lysis, purification,
and analysis could be carried out in less than 2 hours.
Finally, in chapter 4, I showed that it was possible to lower the limit of detection two
orders of magnitude by creating a unique 120 bp labeling probe with 70 bp of dsDNA character
stained with SybrGold dye. After rinsing, this probe could be used to label immobilized target in
a sequence-specific manner. The work of chapters 3 and 4 provide a foundation for a system
capable of diagnosing drug resistance in bacteria via DNA hybridization, labelling in a sequence
specific manner, followed by single molecule analysis. While further development would be
required to incorporate these into a commercial system capable of point-of-need care, the core
requirements for such a device have been demonstrated.
The research conducted from this work demonstrated three major advances, the rapid
separation of plasma and bacteria from a blood sample [Wood]1, the sequence-specific capture
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and labelling of plasmid targets [Hanson]2, and the detection of three targets via multiplex
analysis [Meena]3. The value of my work described in Chapter 4 lies in the development of an
approach that resulted in multiple fluorophores held by a DNA tag that would attach to its target
in a sequence specific manner. My strategy from Chapter 4 lowers the limit of detection by at
least an order of magnitude over methods previously demonstrated. The method from Chapter 4
can be used to label targets of sizes ranging from 90 bp to 2 kbp. This allows working under
sample conditions seen in a clinical setting and provides a foundation for detecting low
concentrations of bacteria without amplification.

5.2. Future Work
The original funding stipulation which excluded amplification-based strategies was based
on the assumption that amplification and blood culture are vulnerable to interference from blood
borne inhibitors, leading to concerns about increased time-to-answer and inaccurate results4,5.
PCR has seen dramatic improvements in both its speed and quality6–8. Particularly successful has
been the slip chip system which was able to amplify sequences directly from blood9. For
monolith purification coupled to single molecule counting to be competitive with digital PCR or
other alternative DNA analysis methods that may emerge, it needs to provide a competitive
advantage in terms of reliability, time, limit of detection, application to assays where
amplification is not feasible, etc.
For example, short DNA molecules would offer an appropriate target since they can be
found in trace amounts and are not readily amplified. Advantages in reliability are seen in the
low background of the final separations (figure 4.5). The sequence-specific nature of the label
can enable reliability by excluding off-target sequences. Further improvements might be made to
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the efficiency of target capture by slowing down the rate of sample loading or ensuring that
every single capture strand in the monolith is oriented for perfect hybridization. Another possible
step to improve hybridization would be to use a modified CAS-9 enzyme to fragment the target
DNA so that all target sequences in a sample are at the same location. Such goals are nontrivial
measures and would need to be evaluated to see if the improvement in efficiency is worth the
tradeoff of time and skill required to implement them.
To compete with digital PCR techniques capable of generating an answer within 40
minutes9–11, monolith assay times would need to be shortened to 15 min, similar to what Knob et
al. demonstrated with synthetic oligonucleotides12. The fluorescence labeling/rinsing step is the
largest hurdle to overcome in pursuit of that goal. As it currently stands, significant amounts of
time are required to load dye into the monolith, ensure that it’s had a chance to saturate the area,
and then rinse it off. Not rinsing the dye off long enough to return the fluorescence to baseline
produced sub-optimal results. Merely optimizing the amount of dye used on the system would
not provide a large enough reduction in time to achieve this goal. The only way I see of keeping
sequence-specific fluorescent labeling as part of the system while reducing the time significantly
is to enact the labeling procedure before or after the target enters the monolith. Enacting it before
would require an interaction that is resistant to adjustments in temperature, i.e. probe sequences
with covalently attached fluorophores or similar tags13,14. Post-column labeling would require
some form of sequence-specific elution followed by combination with a pre-deposited
fluorescent dye.
It’s also important to remember that the monolith system as it is currently constituted
might not represent the most ideal use of its properties. A key advantage of porous monoliths is
their potential for concentrating and labelling multiple targets as they pass through the same
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spatial location. This confers the advantage of saving time and conserving sample for any
automated system with which they may be incorporated.
One important factor to improve the system I developed in Chapter 4 would be for the
probes that label the target to be created using irreversible interactions to attach the fluorescent
molecules. Probably the most direct method to do this would be to assemble components for the
tags using PCR with fluorescently modified deoxynucleotriphosphates (dNTPs). Another
advantage of this strategy would be the possibility of accomplishing these multiple steps in a
single unified step; made possible because of the irreversible nature of the fluorescent
modification.
Chapter 4 demonstrates that reasonable detection can be accomplished by using a 120 bp
DNA sequence with 77 bp of dsDNA character labeled with SyberGold dye. This important
feature of attaching multiple fluorophores to the labeling molecule rather than directly to a small
target, facilitates systems that have the potential to achieve lower limits of detection than
previously reported, avoiding the need to produce large numbers of replicates. It is my hope that
in the future, the use of multi-labeled probes will be seen in clinical settings.
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